Direct detection of early-stage cancers using circulating tumor DNA J Phallen, M Sausen, V Adleff, A Leal, C Hruban, J White, V Anagnostou, ... Science translational medicine 9 (403), eaan2415, 2017 | 1035 | 2017 |
Personalized genomic analyses for cancer mutation discovery and interpretation S Jones, V Anagnostou, K Lytle, S Parpart-Li, M Nesselbush, DR Riley, ... Science translational medicine 7 (283), 283ra53-283ra53, 2015 | 470 | 2015 |
Integrating genomic features for non-invasive early lung cancer detection JJ Chabon, EG Hamilton, DM Kurtz, MS Esfahani, EJ Moding, H Stehr, ... Nature 580 (7802), 245-251, 2020 | 461 | 2020 |
The genomic landscape of response to EGFR blockade in colorectal cancer A Bertotti, E Papp, S Jones, V Adleff, V Anagnostou, B Lupo, M Sausen, ... Nature 526 (7572), 263-267, 2015 | 460 | 2015 |
KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition MS Binkley, YJ Jeon, M Nesselbush, EJ Moding, BY Nabet, D Almanza, ... Cancer discovery 10 (12), 1826-1841, 2020 | 102 | 2020 |
Inferring gene expression from cell-free DNA fragmentation profiles MS Esfahani, EG Hamilton, M Mehrmohamadi, BY Nabet, SK Alig, ... Nature biotechnology 40 (4), 585-597, 2022 | 81 | 2022 |
Lower nasopharyngeal epithelial cell repair and diminished innate inflammation responses contribute to the onset of acute otitis media in otitis-prone children D Verhoeven, M Nesselbush, ME Pichichero Medical microbiology and immunology 202, 295-302, 2013 | 23 | 2013 |
A comprehensive noninvasive approach for the stratification of lung cancer patients for targeted therapies. DM Murphy, SV Angiuoli, B Chesnick, K Galens, S Jones, M Kadan, ... Journal of Clinical Oncology 33 (15_suppl), e22086-e22086, 2015 | 2 | 2015 |
Pan-Cancer assessment of tumor mutational burden using a comprehensive genomic profiling assay. D Nichol, S Jones, SV Angiouli, L Keefer, M Nesselbush, N Sengamalay, ... Journal of Clinical Oncology 36 (5_suppl), 157-157, 2018 | 1 | 2018 |
Abstract P2-01-04: a method for comprehensive genomic analysis of cell free DNA S Parpart-Li, SV Angiuoli, B Chesnick, K Galens, S Jones, M Kadan, ... Cancer Research 76 (4_Supplement), P2-01-04-P2-01-04, 2016 | 1 | 2016 |
A method for comprehensive genomic analysis of cell-free DNA. S Parpart-Li, SV Angiuoli, B Chesnick, K Galens, S Jones, M Kadan, ... Journal of Clinical Oncology 33 (15_suppl), e22070-e22070, 2015 | 1 | 2015 |
Personalized Genomic Analyses for Cancer Mutation Discovery and Interpretation. V Anagnostou, S Jones, K Lytle, S Parpart-Li, M Nesselbush, V Adleff, ... Journal of Clinical Oncology 33 (15_suppl), 1529-1529, 2015 | 1 | 2015 |
MP71-19 ULTRASENSITIVE URINARY LIQUID BIOPSY ANALYSIS FOR BCG RESPONSE ASSESSMENT IN HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER WY Shi, KJ Liu, MS Esfahani, JG Schroers-Martin, M Nesselbush, ... The Journal of Urology 211 (5S), e1169, 2024 | | 2024 |
Cell-free RNA analysis for non-invasive cancer detection and characterization MC Nesselbush, BA Luca, YJ Jeon, I Jabara, CB Meador, MS Binkley, ... Cancer Research 84 (6_Supplement), 6560-6560, 2024 | | 2024 |
An Integrated Multimodal Framework for Noninvasive TCL Disease Detection and Monitoring T Sugio, N Shukla, MS Khodadoust, M Nesselbush, K Kato, SK Alig, ... Blood 142, 1620, 2023 | | 2023 |
Abstract PO-059: Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer MS Binkley, YJ Jeon, M Nesselbush, EJ Moding, B Nabet, D Almanza, ... Clinical Cancer Research 27 (8_Supplement), PO-059-PO-059, 2021 | | 2021 |
Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer. MS Binkley, YJ Jeon, M Nesselbush, EJ Moding, B Nabet, D Almanza, ... CLINICAL CANCER RESEARCH 27 (8), 2021 | | 2021 |
KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer. MS Binkley, YJ Jeon, M Nesselbush, EJ Moding, B Nabet, DS Almanza, ... Journal of Clinical Oncology 38 (15_suppl), 9012-9012, 2020 | | 2020 |
Abstract A027: Analytic validation of a pan-cancer tumor mutational burden assay M Nesselbush, S Jones, L Keefer, N Sengamalay, V Velculescu, L Diaz, ... Molecular Cancer Therapeutics 17 (1_Supplement), A027-A027, 2018 | | 2018 |
Clinical validation of a cell-free DNA liquid biopsy approach for noninvasive molecular profiling M Nesselbush, S Angiuoli, LA Diaz, A Georgiadis, S Glynn, S Jones, ... Cancer Research 77 (13_Supplement), 4954-4954, 2017 | | 2017 |